Who is moving to which position
Resolved 10 April 2026Incoming appointee
1 itemDeparting officer
1 item“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.
To receive treatment for a pre-existing medical condition, and to focus as the executive lead on expanding the AI Robotics Business and New Mechatronics Applications Business, which are growth areas
Will not remain on the Board of Directors (will retire as a director at the conclusion of the Ordinary General Meeting of Shareholders)
The company decided to review its management structure in order to accelerate sustainable growth and enhance corporate value as it enters the first year of its new long-term management plan and new medium-term management plan.
| Item | Details |
|---|---|
| Resolution date | 10 April 2026 |
| Scheduled Appointment Date | 27 May 2026 (formal approval is expected at the 110th Ordinary General Meeting of Shareholders scheduled for 27 May 2026 and at the Board of Directors meeting to be held thereafter) |
| Date of departure | 27 May 2026 (at the conclusion of the 110th Ordinary General Meeting of Shareholders) |
| Name of appointee | Ogasawara Hiroshi (小笠原 浩) |
| Appointee's new position | Representative Director, Chairman and President |
| Appointee's previous position | Representative director and chairman |
| Appointee's date of birth | 19 September 1955 |
| Year the appointee joined the Company | 1979 |
| Number of shares held by the appointee | 66,389 shares (as of the end of February 2026) |
| Name of departing officer | Ogawa Masahiro (小川 昌寛) |
| Former position of departing officer | Representative Director and President |
| New position of departing officer | Executive Officer and Vice Chairman, overseeing the AI Robotics Business and New Mechatronics Applications Business |
| Reason for departure | To receive treatment for a pre-existing medical condition, and to focus as the executive lead on expanding the AI Robotics Business and New Mechatronics Applications Business, which are growth areas |
| Whether the incumbent will remain in office | Will not remain on the Board of Directors (will retire as a director at the conclusion of the Ordinary General Meeting of Shareholders) |
| Reason for change | The company decided to review its management structure in order to accelerate sustainable growth and enhance corporate value as it enters the first year of its new long-term management plan and new medium-term management plan. |
| Number of directors after the change | Not disclosed (the number of outside directors is also not disclosed) |
| Subject to Approval by the General Meeting of Shareholders | Required. The name of the proposal is Not disclosed. The 110th Ordinary General Meeting of Shareholders is scheduled for 27 May 2026. |
Items this document does not state (4)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.As the company enters the first year of its new long-term management plan and new medium-term management plan, it will review its management structure to accelerate sustainable growth and enhance corporate value. Ogawa Masahiro (小川 昌寛) has asked to step down as Representative Director and President in order to focus as the executive lead on expanding the AI Robotics Business and New Mechatronics Applications Business, and to receive treatment for a pre-existing medical condition. The company has accepted his request.